# DAPSONE

NDC: 46708-551
Generic name: DAPSONE
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20260701

FDA application: ANDA213414

## Active ingredients

- DAPSONE: 50 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-551"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-551
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f1301f6-884d-4fc7-a5b2-421b2375b985